Stocks · Healthcare · Medical - Distribution
McKesson Corporation MCK
$902.28 +0.38% Close, Oct 2, 2026 · NYSE · Market cap $105.64B
Inexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $37.37, up 49.1% year over year.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +4.0%).
- The stock is in an uptrend: above its 200-day average for 30 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth52Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 50%
- EPS growth (TTM, YoY)Top 28%
- FCF growth (TTM, YoY)Top 50%
- Revenue growth, 3-year CAGRTop 43%
- Revenue growth accelerationBottom 30%
Quality70Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 3%
- Gross marginBottom 9%
- Operating marginTop 40%
- Cash conversion (OCF / net income)Bottom 45%
- Accruals (lower is better)Bottom 27%
- Net debt / EBITDA (lower is better)Top 46%
- Interest coverTop 6%
Value92Exceptional
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 13%
- Free-cash-flow yieldTop 16%
- EBITDA / enterprise valueTop 18%
- Sales / enterprise valueTop 2%
- P/E vs own 5-year history (lower is better)Top 46%
Momentum68Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 49%
- 6-month returnBottom 45%
- 1-year return vs S&P 500Top 45%
- Distance from 52-week highTop 15%
- Trend checklist (0–4)Top 7%
Revisions56Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 49%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyTop 44%
- Upside to consensus price targetBottom 14%
Stability97Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 12%
- Maximum drawdown, 3 yearsTop 3%
- Beta vs S&P 500 (lower is better)Top 4%
- Net debt / EBITDA (lower is better)Top 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 12.4% | 8.8% | ↓ |
| EPS growth (YoY) | 49.1% | 49.1% | ↑ |
| Gross margin | 3.3% | 3.6% | ↑ |
| Operating margin | 1.1% | 1.6% | ↑ |
| FCF margin | 1.5% | 1.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.8% | 12.4% | ↓ | Top 50% |
| EPS growth (TTM, YoY) | 49.1% | 49.1% | ↑ | Top 28% |
| Gross margin | 3.6% | 3.3% | ↑ | Bottom 9% |
| Operating margin | 1.6% | 1.1% | ↑ | Top 40% |
| Net margin | 1.1% | 0.8% | ↑ | — |
| Free-cash-flow margin | 1.5% | 1.5% | ↑ | — |
| Return on invested capital | 27.9% | — | Top 3% | |
| Revenue growth, 3-year CAGR | 13.4% | — | Top 43% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.49×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.91×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 43.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.37%
- Net buyback yield (TTM)
- 4.98%
- Shareholder yield
- 5.35%
- Share count change, 1 year
- -5.0%
- Share count change, 3-year CAGR
- -4.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +4.0%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $953.00
- Target vs current price
- +5.6%
- Analysts with a rating
- 31
- Share rating Buy or Strong Buy
- 81%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +3.9% | +5.6% | +8.6% | +9.2% | — |
| May 7, 2026 | +1.1% | +1.5% | -0.9% | +1.8% | +11.2% |
| Feb 4, 2026 | +1.9% | -3.4% | +9.9% | +15.0% | -4.2% |
| Nov 5, 2025 | +9.2% | +0.3% | +1.8% | -4.3% | +0.6% |
| Aug 6, 2025 | +1.5% | -0.8% | -7.1% | -2.6% | +13.8% |
| May 8, 2025 | +3.0% | -4.4% | -5.5% | -1.5% | -1.6% |
| Feb 5, 2025 | -6.6% | +0.6% | +1.2% | +6.0% | +17.1% |
| Nov 6, 2024 | +2.8% | +4.6% | +17.6% | +16.5% | +14.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $9.93 | $9.56 | +3.9% | $105.38B |
| May 7, 2026 | $11.69 | $11.56 | +1.1% | $96.30B |
| Feb 4, 2026 | $9.34 | $9.17 | +1.9% | $106.16B |
| Nov 5, 2025 | $9.86 | $9.03 | +9.2% | $103.15B |
| Aug 6, 2025 | $8.26 | $8.14 | +1.5% | $97.83B |
| May 8, 2025 | $10.12 | $9.83 | +3.0% | $90.82B |
| Feb 5, 2025 | $8.03 | $8.60 | -6.6% | $95.29B |
| Nov 6, 2024 | $7.07 | $6.88 | +2.8% | $93.65B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 24.1× | 26.7× | 42th | Top 13% |
| P/E (forward) | 20.2× | — | — | — |
| EV / EBITDA | 15.7× | — | — | Top 18% |
| EV / Sales | 0.27× | — | — | Top 2% |
| Free-cash-flow yield | 5.85% | — | — | Top 16% |
| Earnings yield | 4.14% | — | — | Top 13% |
P/E over the past five years
Range 15.4× – 45.3× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +17.9%
- Earnings per share growth (TTM)
- +49.1%
- Change in P/E multiple
- -16.4%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 2
- Days above the 200-day average
- 30
- 50-day average slope (20 days)
- +4.0%
- 200-day average slope (20 days)
- +0.5%
- Distance from 50-day average
- +2.8%
- Distance from 200-day average
- +6.5%
- RSI (14)
- 56.9
- Relative volume
- 0.88×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 32.0%
- Volatility vs own 5-year history
- 89th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.10
- Correlation with S&P 500
- 0.06
- Current drawdown from 1-year high
- -9.4%
- Maximum drawdown, 3 years
- -27.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 3, 2026 | May 11, 2026 | -27.2% | 48 days | Not yet recovered |
| Aug 2, 2024 | Sep 26, 2024 | -24.0% | 38 days | 105 days (Feb 28, 2025) |
| Nov 3, 2022 | Mar 15, 2023 | -15.7% | 89 days | 44 days (May 17, 2023) |
| May 26, 2022 | Jun 17, 2022 | -10.7% | 15 days | 25 days (Jul 26, 2022) |
| Nov 25, 2025 | Dec 9, 2025 | -10.6% | 9 days | 39 days (Feb 5, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $105.64B
- P/E (TTM)
- 24.1
- EPS, diluted (TTM)
- $37.37
- Revenue (TTM)
- $410.98B
- Dividend yield
- 0.38%
- 52-week range
- $723.68 – $999.00
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $263.97B | $276.71B | $308.95B | $359.05B | $403.43B |
| Gross profit | $12.65B | $11.87B | $12.20B | $12.48B | $14.55B |
| Operating income | $2.72B | $4.45B | $3.93B | $4.37B | $6.45B |
| Net income | $1.11B | $3.56B | $3.00B | $3.29B | $4.76B |
| EPS (diluted) | $7.23 | $25.04 | $22.39 | $25.72 | $38.38 |
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93.65B | $95.29B | $90.82B | $97.83B | $103.15B | $106.16B | $96.30B | $105.38B |
| Net income | $241.0M | $879.0M | $1.26B | $784.0M | $1.11B | $1.19B | $1.68B | $614.0M |
| EPS (diluted) | $1.86 | $6.94 | $10.01 | $6.25 | $8.92 | $9.59 | $13.71 | $5.15 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $4.43B | $5.16B | $4.31B | $6.08B | $6.16B |
| Capital expenditure | -$535.0M | -$558.0M | -$687.0M | -$859.0M | -$745.0M |
| Free cash flow | $3.90B | $4.60B | $3.63B | $5.23B | $5.41B |
| Dividends paid | -$277.0M | -$292.0M | -$314.0M | -$345.0M | -$381.0M |
| Net share buybacks | -$3.30B | -$3.48B | -$2.91B | -$3.04B | -$4.66B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $5.16B
- Total assets
- $88.33B
- Total liabilities
- $92.19B
- Total debt
- $11.70B
- Net debt
- $6.54B
- Shareholders’ equity
- -$4.24B
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 1, 2026 | $0.94 | Oct 1, 2026 |
| Jun 1, 2026 | $0.82 | Jul 1, 2026 |
| Mar 2, 2026 | $0.82 | Apr 1, 2026 |
| Dec 1, 2025 | $0.82 | Jan 2, 2026 |
| Sep 2, 2025 | $0.82 | Oct 1, 2025 |
| Jun 2, 2025 | $0.71 | Jul 1, 2025 |
| Mar 3, 2025 | $0.71 | Apr 1, 2025 |
| Dec 2, 2024 | $0.71 | Jan 2, 2025 |
Short interest
- Shares sold short
- 2,903,573
- Days to cover
- 3.39
- Change vs previous report
- +2.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jan 5, 1998
- 2-for-1